We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-13.49%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$42.1B
AUM Growth
-$7.13B
(-14%)
Cap. Flow
+$617M
Cap. Flow
% of AUM
1.47%
Top 10 Holdings %
Top 10 Hldgs %
24.6%
Holding
2,253
New
45
Increased
584
Reduced
402
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$209M |
| 2 |
AT&T
T
|
+$156M |
| 3 |
ExxonMobil
XOM
|
+$122M |
| 4 |
Johnson & Johnson
JNJ
|
+$84.2M |
| 5 |
Walmart Inc
WMT
|
+$77.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$209M |
| 2 |
Chevron
CVX
|
+$115M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$95.1M |
| 4 |
Meta Platforms (Facebook)
META
|
+$80.8M |
| 5 |
Eli Lilly
LLY
|
+$66.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.42% |
| 2 | Healthcare | 18.92% |
| 3 | Financials | 13.22% |
| 4 | Consumer Discretionary | 8.69% |
| 5 | Industrials | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Silicon Laboratories
SLAB
$7.17B
| $1.77M | ﹤0.01% |
12,594
| – | – |
|
852
Brunswick
BC
$5.34B
| $1.76M | ﹤0.01% |
26,924
| – | – |
|
|
CDAK
853
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $1.75M | ﹤0.01% |
609,105
-59,383
| -9% | -$209K |
|
854
Vir Biotechnology
VIR
$1.45B
| $1.75M | ﹤0.01% |
68,689
-44,820
| -39% | -$1.05M |
|
|
FISV
855
Fiserv Inc
FISV
$28.8B
| $1.74M | ﹤0.01% |
19,549
-6,490
| -25% | -$629K |
|
|
SWAV
856
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $1.74M | ﹤0.01% |
9,080
+1,450
| +19% | +$256K |
|
857
Silgan Holdings
SLGN
$5.05B
| $1.73M | ﹤0.01% |
41,798
| – | – |
|
|
LSXMA
858
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $1.73M | ﹤0.01% |
65,192
-7,009
| -10% | -$210K |
|
859
Acuity Brands
AYI
$10.2B
| $1.73M | ﹤0.01% |
11,200
| – | – |
|
860
NovoCure
NVCR
$1.93B
| $1.71M | ﹤0.01% |
24,640
| – | – |
|
861
Xenon Pharmaceuticals
XENE
$6.24B
| $1.71M | ﹤0.01% |
56,291
+47,771
| +561% | +$1.44M |
|
862
Patterson-UTI
PTEN
$3.5B
| $1.71M | ﹤0.01% |
108,480
| – | – |
|
863
First Financial Bankshares
FFIN
$5B
| $1.7M | ﹤0.01% |
43,364
| – | – |
|
864
State Street Materials Select Sector SPDR ETF
XLB
$8.85B
| $1.7M | ﹤0.01% |
46,220
-4,556
| -9% | -$191K |
|
865
AGNC Investment
AGNC
$12.7B
| $1.7M | ﹤0.01% |
153,480
-81,520
| -35% | -$966K |
|
866
Regal Rexnord
RRX
$13.4B
| $1.7M | ﹤0.01% |
14,934
| – | – |
|
|
SGEN
867
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.7M | ﹤0.01% |
9,579
-2,274
| -19% | -$328K |
|
868
Cousins Properties
CUZ
$5.21B
| $1.69M | ﹤0.01% |
57,792
-4,635
| -7% | -$160K |
|
869
Affiliated Managers Group
AMG
$9.55B
| $1.69M | ﹤0.01% |
14,465
-5,475
| -27% | -$705K |
|
870
Johnson Controls International
JCI
$84B
| $1.69M | ﹤0.01% |
35,175
-5,005
| -12% | -$279K |
|
871
Regenxbio
RGNX
$602M
| $1.68M | ﹤0.01% |
68,111
+46,441
| +214% | +$1.16M |
|
872
Assured Guaranty
AGO
$3.78B
| $1.68M | ﹤0.01% |
30,040
| – | – |
|
873
Murphy Oil
MUR
$5.39B
| $1.68M | ﹤0.01% |
55,485
| – | – |
|
874
AMN Healthcare
AMN
$1.32B
| $1.67M | ﹤0.01% |
15,187
| – | – |
|
875
Bank OZK
OZK
$5.56B
| $1.66M | ﹤0.01% |
44,273
-4,825
| -10% | -$190K |
|
Similar funds
SCP
Ensign Peak Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Ensign Peak Advisors held 2,253 positions worth $42.1B, down 14% from $49.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q2 2022 filing shows 45 new, 584 increased, 402 reduced and 95 closed positions. Its largest new stake was State Street Utilities Select Sector SPDR ETF: 455,528 shares worth $16M. The largest sale was iShares Russell 2000 ETF, an estimated $209M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q2 2022 buy was State Street Utilities Select Sector SPDR ETF: 455,528 shares worth $16M.
- Ensign Peak Advisors added most to Merck in Q2 2022, an estimated $209M increase.
- Ensign Peak Advisors's biggest Q2 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $209M.
- Ensign Peak Advisors fully exited VMware, Inc in Q2 2022, selling an estimated $20.8M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $42.1B portfolio in Q2 2022.
- Ensign Peak Advisors opened 45 new positions and closed 95 in Q2 2022.
- Ensign Peak Advisors's portfolio value fell 14% quarter-over-quarter to $42.1B.
Based on Ensign Peak Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.